Table 2.
Viruses identified in patients with upper respiratory tract infection.
| Viruses | Single infections (n = 62) | Coinfections (n = 26)¶ | All infections (n = 88)$ |
|---|---|---|---|
| Number (%) | Number (%) | Number (%) | |
| hRV | 29 (46.8) | 7 (26.9) | 36 (40.9) |
| hCoV-OC43 | 9 (14.5) | 5 (19.2) | 14 (15.9) |
| hCoV-HKU1 | 2 (3.2) | 0 | 2 (2.3) |
| hCoV-NL63 | 1 (1.6) | 0 | 1 (1.1) |
| hRSV-A | 1 (1.6) | 2 (7.7) | 3 (3.4) |
| hRSV-B | 7 (11.3) | 2 (7.7) | 9 (10.2) |
| FluA | 7 (11.3) | 5 (19.2) | 12 (13.6) |
| FluB | 2 (3.2) | 0 (0.0) | 2 (2.3) |
| EV | 2 (3.2) | 1 (3.9) | 3 (3.4) |
| hAdv | 1 (1.6) | 4 (15.4) | 5 (5.7) |
| hMPVA | 1 (1.6) | 0 | 1 (1.1) |
¶Coinfections include all viruses detected from the 13 coinfected patients (2 × 13).
$Includes viruses detected in single infections (62) and in coinfections (26).